Discover how CRISPR base editing technology is revolutionizing T-cell engineering for cancer and autoimmune disease treatment without dangerous DNA breaks.
A groundbreaking therapy is teaching immune cells to hunt down one of medicine's most elusive cancers—with astonishing results.